Cargando…

Effects of Intermittent Parathyroid Hormone 1–34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women

BACKGROUND: Intermittent parathyroid hormone (PTH) 1–34 administration stimulates osteogenesis and increases bone marrow mesenchymal stem cell (MSC) density; however, its effect on the circulating MSCs is unknown. This study aimed to examine the effect of intermittent PTH 1–34 administration on circ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Yutao, Xia, Han, Kang, Liang, Sun, Quan, Su, Zhe, Hao, Congqiang, Xue, Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6330838/ https://www.ncbi.nlm.nih.gov/pubmed/30620727 http://dx.doi.org/10.12659/MSM.913752

Ejemplares similares

Intermittent Parathyroid Hormone Alters Gut Microbiota in Ovariectomized Osteoporotic Rats
por: Zhou, Jiaming, et al.
Publicado: (2022)

Optimal timing for intermittent administration of parathyroid hormone (1–34) for distraction osteogenesis in rabbits
por: Inada, Narisaku, et al.
Publicado: (2022)

Intermittent Administration of Parathyroid Hormone 1–34 Enhances Osteogenesis of Human Mesenchymal Stem Cells by Regulating Protein Kinase Cδ
por: Kuo, Shu-Wen, et al.
Publicado: (2017)

Intermittent Administration of Parathyroid Hormone [1–34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model
por: Bi, Fanggang, et al.
Publicado: (2015)

Effects of Intermittent Administration of Parathyroid Hormone (1-34) on Bone Differentiation in Stromal Precursor Antigen-1 Positive Human Periodontal Ligament Stem Cells
por: Wang, Xiaoxiao, et al.
Publicado: (2016)

Effects of Intermittent Administration of Parathyroid Hormone and Parathyroid Hormone‐Related Protein on Fracture Healing: A Narrative Review of Animal and Human Studies
por: Yamashita, Junro, et al.
Publicado: (2019)

Intermittently Administered Parathyroid Hormone [1–34] Promotes Tendon-Bone Healing in a Rat Model
por: Bi, Fanggang, et al.
Publicado: (2014)

Optimal intermittent administration interval of parathyroid hormone 1‐34 for bone morphogenetic protein‐induced bone formation in a rat spinal fusion model
por: Abe, Tetsutaro, et al.
Publicado: (2021)

A Recombinant Parathyroid Hormone‐Related Peptide Locally Applied in Osteoporotic Bone Defect
por: Wang, Yi, et al.
Publicado: (2023)

Efficacy and safety of recombinant human parathyroid hormone (1–34) are similar to those of alendronate in the treatment of postmenopausal osteoporosis
por: Deng, Jing, et al.
Publicado: (2018)

Histological and histomorphometric aspects of continual intermittent parathyroid hormone administration on osseointegration in osteoporosis rabbit model
por: Oki, Yoshifumi, et al.
Publicado: (2022)

Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation
por: Osagie-Clouard, L., et al.
Publicado: (2017)

Efficacy and Safety of the Biosimilar Recombinant Human Parathyroid Hormone Cinnopar(®) in Postmenopausal Osteoporotic Women: A Randomized Double-blind Clinical Trial
por: TABATABAEI-MALAZY, Ozra, et al.
Publicado: (2018)

Modeling and remodeling effects of intermittent administration of teriparatide (parathyroid hormone 1-34) on bone morphogenetic protein-induced bone in a rat spinal fusion model
por: Kaito, Takashi, et al.
Publicado: (2016)

Nasal Administration and Plasma Pharmacokinetics of Parathyroid Hormone Peptide PTH 1-34 for the Treatment of Osteoporosis
por: Pearson, Richard G., et al.
Publicado: (2019)

Intermittent parathyroid hormone 1–34 induces oxidation and deterioration of mineral and collagen quality in newly formed mandibular bone
por: Yoshioka, Yohsuke, et al.
Publicado: (2019)

Short-term intermittent administration of parathyroid hormone facilitates osteogenesis by different mechanisms in cancellous and cortical bone
por: Ogura, Kenji, et al.
Publicado: (2016)

Parathyroid Hormone Disturbances in Postmenopausal Women with Distal Forearm Fracture
por: Wihlborg, Axel, et al.
Publicado: (2021)

Intermittent parathyroid hormone (1–34) supplementation of bone marrow stromal cell cultures may inhibit hypertrophy, but at the expense of chondrogenesis
por: Music, Ena, et al.
Publicado: (2020)

Enhancement of the effects of intermittent parathyroid hormone (1-34) by bone morphogenetic protein in a rat femoral open fracture model
por: Kanezaki, Shozo, et al.
Publicado: (2019)

Intermittent administration of parathyroid hormone improves the repairing process of rat calvaria defects: A histomorphometric and radiodensitometric study
por: Silva, Eduardo-de-Paula, et al.
Publicado: (2015)

Intermittent Administration of Parathyroid Hormone Enhances Odonto/Osteogenic Differentiation of Stem Cells from the Apical Papilla via JNK and P38 MAPK Pathways
por: Pang, Xiyao, et al.
Publicado: (2020)

Parathyroid hormone (1-34) promotes the effects of 3D printed scaffold-seeded bone marrow mesenchymal stem cells on meniscus regeneration
por: Zhao, Wen, et al.
Publicado: (2020)

Triweekly administration of parathyroid hormone (1–34) accelerates bone healing in a rat refractory fracture model
por: Kumabe, Yohei, et al.
Publicado: (2017)

The Transcription Factor Foxc1 Promotes Osteogenesis by Directly Regulating Runx2 in Response of Intermittent Parathyroid Hormone (1–34) Treatment
por: Ouyang, Ningjuan, et al.
Publicado: (2020)

Effect of Intermittent Versus Continuous Parathyroid Hormone in the Cardiovascular System of Rats
por: Smajilovic, Sanela, et al.
Publicado: (2010)

Anabolic Response of Intermittent Parathyroid Hormone and Alendronate on the Osteochondral Tissue of TMJ
por: Chen, Po-Jung, et al.
Publicado: (2022)

Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures
por: Cohn Yakubovich, Doron, et al.
Publicado: (2017)

Development and in vivo evaluation of intranasal formulations of parathyroid hormone (1-34)
por: Wang, Dan, et al.
Publicado: (2021)

Effect of parathyroid hormone on healing in osteoporotic fractures via a phospholipase C-independent pathway
por: Li, Wei-Long, et al.
Publicado: (2017)

Full length parathyroid hormone (1–84) in the treatment of osteoporosis in postmenopausal women
por: Jódar-Gimeno, Esteban
Publicado: (2007)

Self-Dissolving Microneedle Arrays for Transdermal Absorption Enhancement of Human Parathyroid Hormone (1-34)
por: Naito, Chihiro, et al.
Publicado: (2018)

Intermittent parathyroid hormone increases stability and improves osseointegration of initially unstable implants
por: Staats, Kevin, et al.
Publicado: (2022)

The influence of parathyroid hormone 1-34 on the osteogenic characteristics of adipose- and bone-marrow-derived mesenchymal stem cells from juvenile and ovarectomized rats
por: Osagie-Clouard, Liza, et al.
Publicado: (2019)

In vitro cell behaviors of bone mesenchymal stem cells derived from normal and postmenopausal osteoporotic rats
por: Liu, Qian, et al.
Publicado: (2018)

Intermittent parathyroid hormone improve bone microarchitecture of the mandible and femoral head in ovariectomized rats
por: Chen, Ying-Ju, et al.
Publicado: (2017)

The combined effect of Parathyroid hormone (1–34) and whole-body Vibration exercise in the treatment of postmenopausal OSteoporosis (PaVOS study): a randomized controlled trial
por: Jepsen, D. B., et al.
Publicado: (2019)

Effect of parathyroid hormone on early chondrogenic differentiation from mesenchymal stem cells
por: Zhang, Yun, et al.
Publicado: (2014)

Circulating Carboxylated Osteocalcin Correlates With Skeletal Muscle Mass and Risk of Fall in Postmenopausal Osteoporotic Women
por: Vitale, Jacopo Antonino, et al.
Publicado: (2021)

Effects of parathyroid hormone (1-34) on the regulation of the lysyl oxidase family in ovariectomized mice
por: Cai, Linyi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6ohv1lc6stqn0h73i8ov0lmifn